ROBO Global Healthcare Technology and Innovation ETF(HTEC · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $26.12 – $38.50
- YTD
- -1.37%
- IV Rank (30D)
- 53.18
- Straddle Price
- $2.35
- P/C Vol Ratio
- 0.00
ROBO Global Healthcare Technology and Innovation ETF (HTEC) ETF
- Exchange
- ARCX
- Inception
- 2019-06-24
- Has Options
- Yes
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2025-12-30 | 2025-12-31 | $0.3463 | CD |
| 2021-12-28 | 2021-12-31 | $0.0230 | CD |
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| MRNA | MODERNA, INC. | 2.20% | Equity (common) | US |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 2.18% | Equity (common) | US |
| GH | GUARDANT HEALTH, INC. | 2.16% | Equity (common) | US |
| ADPT | Adaptive Biotechnologies Corp | 2.13% | Equity (common) | US |
| PEN | PENUMBRA, INC. | 2.12% | Equity (common) | US |
| AXGN | AxoGen, Inc. | 2.02% | Equity (common) | US |
| ILMN | ILLUMINA, INC. | 2.00% | Equity (common) | US |
| VRTX | VERTEX PHARMACEUTICALS INCORPORATED | 1.99% | Equity (common) | US |
| TWST | Twist Bioscience Corp | 1.97% | Equity (common) | US |
| SYK | STRYKER CORPORATION | 1.96% | Equity (common) | US |
| TMO | THERMO FISHER SCIENTIFIC INCORPORATED | 1.95% | Equity (common) | US |
| — | EUROFINS SCIENTIFIC SE | 1.94% | Equity (common) | FR |
| LIVN | LIVANOVA PLC | 1.88% | Equity (common) | US |
| — | Siemens Healthineers AG | 1.88% | Equity (common) | DE |
| BSX | BOSTON SCIENTIFIC CORPORATION | 1.85% | Equity (common) | US |
| — | Koninklijke Philips N.V. | 1.85% | Equity (common) | NL |
| REGN | REGENERON PHARMACEUTICALS, INC. | 1.84% | Equity (common) | US |
| NTRA | NATERA, INC. | 1.83% | Equity (common) | US |
| NOVT | NOVANTA INC. | 1.82% | Equity (common) | US |
| IQV | IQVIA HOLDINGS INC | 1.80% | Equity (common) | US |
| — | Lonza Group AG | 1.77% | Equity (common) | CH |
| — | Roche Holding AG | 1.75% | Equity (common) | CH |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1.73% | Equity (common) | US |
| QGEN | Qiagen N.V. | 1.72% | Equity (common) | US |
| MEDP | MEDPACE HOLDINGS, INC. | 1.71% | Equity (common) | US |
| GKOS | GLAUKOS CORPORATION | 1.70% | Equity (common) | US |
| ISRG | INTUITIVE SURGICAL, INC. | 1.69% | Equity (common) | US |
| — | JD Health International Inc | 1.69% | Equity (common) | HK |
| EXAS | EXACT SCIENCES CORPORATION | 1.68% | Equity (common) | US |
| NVCR | NOVOCURE LIMITED | 1.66% | Equity (common) | US |
| GMED | GLOBUS MEDICAL, INC. | 1.66% | Equity (common) | US |
| GRAL | Grail Inc | 1.65% | Equity (common) | US |
| DHR | DANAHER CORPORATION | 1.65% | Equity (common) | US |
| CDNA | CAREDX, INC. | 1.63% | Equity (common) | US |
| INCY | INCYTE CORPORATION | 1.62% | Equity (common) | US |
| — | Tecan Group AG | 1.62% | Equity (common) | CH |
| — | DIASORIN S.P.A. | 1.60% | Equity (common) | IT |
| — | EDWARDS LIFESCIENCES CORPORATION | 1.58% | Equity (common) | US |
| AORT | ARTIVION, INC. | 1.56% | Equity (common) | US |
| — | BECTON, DICKINSON AND COMPANY | 1.50% | Equity (common) | US |
| BMY | BRISTOL-MYERS SQUIBB COMPANY | 1.50% | Equity (common) | US |
| — | ABBOTT LABORATORIES | 1.45% | Equity (common) | US |
| TEM | TEMPUS AI, INC | 1.45% | Equity (common) | US |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 1.43% | Equity (common) | US |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC. | 1.42% | Equity (common) | US |
| BMRN | BIOMARIN PHARMACEUTICAL INC. | 1.41% | Equity (common) | US |
| A | AGILENT TECHNOLOGIES, INC. | 1.38% | Equity (common) | US |
| OMCL | OMNICELL, INC. | 1.37% | Equity (common) | US |
| IRTC | IRHYTHM HOLDINGS, INC. | 1.36% | Equity (common) | US |
| — | BIO-RAD LABORATORIES, INC. | 1.36% | Equity (common) | US |
| # | Symbol | Issuer | Weight | Value |
|---|---|---|---|---|
| 1 | MODERNA INC COMMON STOCK | MODERNA, INC. | 2.20% | $1.2M |
| 2 | ARROWHEAD PHARMACEUTICALS IN COMMON STOCK | ARROWHEAD PHARMACEUTICALS, INC. | 2.18% | $1.2M |
| 3 | GUARDANT HEALTH INC COMMON STOCK | GUARDANT HEALTH, INC. | 2.16% | $1.2M |
| 4 | ADAPTIVE BIOTECHNOLOGIES COMMON STOCK | Adaptive Biotechnologies Corp | 2.13% | $1.2M |
| 5 | PENUMBRA INC COMMON STOCK | PENUMBRA, INC. | 2.12% | $1.2M |
| 6 | AXOGEN INC COMMON STOCK | AxoGen, Inc. | 2.02% | $1.1M |
| 7 | ILLUMINA INC COMMON STOCK | ILLUMINA, INC. | 2.00% | $1.1M |
| 8 | VERTEX PHARMACEUTICALS INC COMMON STOCK | VERTEX PHARMACEUTICALS INCORPORATED | 1.99% | $1.1M |
| 9 | TWIST BIOSCIENCE CORP COMMON STOCK | Twist Bioscience Corp | 1.97% | $1.1M |
| 10 | STRYKER CORP COMMON STOCK | STRYKER CORPORATION | 1.96% | $1.1M |
| 11 | THERMO FISHER SCIENTIFIC INC COMMON STOCK | THERMO FISHER SCIENTIFIC INCORPORATED | 1.95% | $1.1M |
| 12 | EUROFINS SCIENTIFIC COMMON STOCK | EUROFINS SCIENTIFIC SE | 1.94% | $1.1M |
| 13 | LIVANOVA PLC COMMON STOCK | LIVANOVA PLC | 1.88% | $1.0M |
| 14 | SIEMENS HEALTHINEERS AG COMMON STOCK | Siemens Healthineers AG | 1.88% | $1.0M |
| 15 | BOSTON SCIENTIFIC CORP COMMON STOCK | BOSTON SCIENTIFIC CORPORATION | 1.85% | $1.0M |
| 16 | KONINKLIJKE PHILIPS NV COMMON STOCK | Koninklijke Philips N.V. | 1.85% | $1.0M |
| 17 | REGENERON PHARMACEUTICALS COMMON STOCK | REGENERON PHARMACEUTICALS, INC. | 1.84% | $1.0M |
| 18 | NATERA INC COMMON STOCK | NATERA, INC. | 1.83% | $1.0M |
| 19 | NOVANTA INC COMMON STOCK | NOVANTA INC. | 1.82% | $998960 |
| 20 | IQVIA HOLDINGS INC COMMON STOCK | IQVIA HOLDINGS INC | 1.80% | $991026 |
| 21 | LONZA GROUP AG-REG COMMON STOCK | Lonza Group AG | 1.77% | $975618 |
| 22 | ROCHE HOLDING AG-GENUSSCHEIN COMMON STOCK | Roche Holding AG | 1.75% | $964135 |
| 23 | CHARLES RIVER LABORATORIES COMMON STOCK | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1.73% | $952843 |
| 24 | QIAGEN N.V. COMMON STOCK | Qiagen N.V. | 1.72% | $942767 |
| 25 | MEDPACE HOLDINGS INC COMMON STOCK | MEDPACE HOLDINGS, INC. | 1.70% | $937210 |
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | -0.46% | 6 |
| Feb | -3.39% | 6 |
| Mar | -0.97% | 6 |
| Apr | -2.57% | 6 |
| May | -0.44% | 6 |
| Jun | +1.88% | 6 |
| Jul | +4.21% | 5 |
| Aug | -1.60% | 5 |
| Sep | -4.28% | 5 |
| Oct | -0.22% | 5 |
| Nov | +4.73% | 5 |
| Dec | +0.54% | 5 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
- IV Rank (30D)
- 53.18
- IV Rank (7D)
- 100
- Avg IV
- 46.2%
- Straddle (30D)
- $2.35
- Straddle (7D)
- $1.45
- P/C Volume
- 0.00
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
- Beta (1Y vs SPY)
- 1.03
- Correlation (SPY)
- 60.2%
- R²
- 0.36
- Ann. Volatility
- 21.0%
- SPY Volatility
- 12.3%
Above average volatility - stock moves with market amplification
Click any bar to view the full quote for that stock.
| Symbol | Price | 1 Day | 1 Week | 1 Month |
|---|